Skip to main content
Clinical Trials/NCT04736641
NCT04736641
Unknown
N/A

Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire

Gazi University1 site in 1 country105 target enrollmentMarch 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hip Disease
Sponsor
Gazi University
Enrollment
105
Locations
1
Primary Endpoint
Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ)
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ).

Detailed Description

There are a number of medical assessment tools for various diseases, but in most cases such tools are designed to reflect the perspective of healthcare providers, not perspective of patients. In addition to clinical results, it is necessary to evaluate the quality of life of patients when measuring the effect of medical treatments. Thus, evaluation criteria which can be useful as patient-reported outcome indices, have received increasing attention in recent years. Health-related quality of life provides a patient-reported assessment. Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) evaluates quality of life related to hip disorders. It is also a guide in determining the expectations of individuals in the treatment process. It consists of 3 subscales (pain, movement and mental) and 20 items. Hip condition and pain are evaluated with a 100 mm scale. 20 items are scaled likert with values between 0 and 4. "0" means "strongly agree", "1" means "agree", "2" means "uncertain", "3" means "disagree" and "4" means "strongly disagree". The study is planned with 105 individuals with hip disease. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in JOAHDEQ, Oxford Hip Score, International Hip Outcome Tool-12, Short Form-36, and Visual Analog Scale Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
September 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Halime ARIKAN

Research Assistant

Gazi University

Eligibility Criteria

Inclusion Criteria

  • Any diagnosed hip disease,
  • Chronic hip pain,
  • History of pain when lying or during weight-bearing activities, aggravated by activity for more than 3 months.

Exclusion Criteria

  • Lumbar spine nerve root findings,
  • History of lumbar spine or hip surgery,
  • Corticosteroid injection to hip in the past 3 months.

Outcomes

Primary Outcomes

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ)

Time Frame: 15 minutes

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire is designed to evaluate quality of life related to hip disorders.

Study Sites (1)

Loading locations...

Similar Trials